Further, a recent clinical study that examined the sleep architecture and CSF biomarkers (tau and amyloid-β42) in patients with AD (which progressed from having subjective cognitive impairment to mild cognitive impairment to AD), found that both REM and NREM sleep were disturbed. Here, MAPT is linked to Cognitive impairment.